During the past decade, Kashani University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kashani University Hospital" are "Lateral Epicondylitis" (1 trials), "Limb Defects" (1 trials), "Neuromyelitis Optica Spectrum Disorder" (1 trials) and "Secondary Progressive Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Kashani University Hospital" in a lesser frequency.

Most popular intervention types in "Kashani University Hospital" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "Azathioprine" (1 trials), "Depomedrol" (1 trials), "Glatiramer Acetate" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kashani University Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Kashani University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kashani University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kashani University Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".